Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026
Go back to Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026| (NASDAQ: FRNM) | Delayed: 14.01 -0.05 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.06 | 52 Week High | $ | |||
| Open | $14.14 | 52 Week Low | $ | |||
| Day High | $14.42 | P/E | N/A | |||
| Day Low | $13.92 | EPS | $ | |||
| Volume | 381,706 | |||||



